Akums’ Haridwar factory receives ANVISA GMP certification for sterile manufacturing plant
This certification validates the plant’s robust capabilities in manufacturing a wide range of sterile dosage forms
This certification validates the plant’s robust capabilities in manufacturing a wide range of sterile dosage forms
The inspection was conducted from July 22-25, 2025
This GMP certification for our sterile drug product manufacturing facility, Goa Plant II is a testament to our relentless efforts to supply quality and affordable medicines across geographies
This achievement underscores our unwavering commitment to upholding the highest standards of quality, safety, and regulatory compliance
This was a full GMP inspection of the entire facility with specific focus on Ondansetron Oral Film drug product
BASF strengthens its commitment to the biopharma and pharmaceutical ingredients industries through a new investment in North America
Certification bolsters Venus Remedies' position in PIC/S markets, reinforcing commitment to global quality standards
The inspection conducted from December 16, 2024 to December 20, 2024 by the Brazil Health Regulatory Agency (ANVISA)
This approval marks a significant milestone in OneSource’s ongoing commitment to quality and regulatory compliance
Subscribe To Our Newsletter & Stay Updated